Xerava

Active Ingredient(s): Eravacycline Dihydrochloride
FDA Approved: * August 27, 2018
Pharm Company: * TETRAPHASE PHARMS
Category: Antibiotics

Eravacycline (TP-434, Xerava) is a synthetic halogenated tetracycline class antibiotic in development by Tetraphase Pharmaceuticals. It is closely related to tigecycline. It has a broad spectrum of activity including many multi-drug resistant strains of bacteria. Phase III studies in complicated intra-abdominal infections (cIAI)[1] and complicated urinary tract infections (cUTI)[2] were recently completed with mixed results. Eravacycline has been granted fast t... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Xerava 50 mg Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 71773-050

Labeler:

Tetraphase Pharmaceuticals, Inc.

Xerava 100 mg Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 71773-100

Labeler:

Tetraphase Pharmaceuticals, Inc.